Price Chart

DATE TIME TYPE PERIOD REPORTED
EPS
ESTIMATED
EPS
SURPRISE
11/09/2022* -- Results Q3 2022 -- 0.31 --
11/09/2022* 16:30 EST Earnings Call Q3 2022 -- -- --
08/04/2022 -- Results Q2 2022 0.78 0.73 6.85%
08/04/2022 16:30 EST Earnings Call Q2 2022 -- -- --
05/03/2022 -- Results Q1 2022 5.08 3.86 31.61%
05/03/2022 16:30 EST Earnings Call Q1 2022 -- -- --
02/23/2022 -- Results Q4 2021 3.48 2.67 30.58%
02/23/2022 16:30 EST Earnings Call Q4 2021 -- -- --
*Estimated Date/Time

Earnings

Next Report Date 11/09/2022 (est.)
EPS Estimate Upgrade
Last Actual EPS Upgrade

Loading chart...
Last Report Date 08/04/2022
Beat/Miss Upgrade
Return Since -16.44%
Last FQE 06/30/2022
Next FQE 09/30/2022

Profile

Edit
Fulgent Genetics Inc is a technology company that focuses on genetic testing to provide physicians with clinically actionable diagnostic information. Genetic testing offers the possibility of early identification of a disease or a genetic predisposition to disease and enhanced disease treatment and prognosis. Fulgent's product portfolio includes Genes & Panels, Known Mutation, Genomic Testing, Hereditary Cancer, Carrier Screening, Tumor Profiling, and Sequencing Service. Its customers are categorized as Insurance; Institutional, which includes hospitals, medical institutions, laboratories, governmental bodies, municipalities, and large corporations; and Patients. The geographical segments are the United States, which generates the vast majority of the revenue; and Foreign.
URL https://www.fulgentgenetics.com
Investor Relations URL https://fulgentgenetics.gcs-web.com
HQ State/Province California
Sector Healthcare
Industry Diagnostics & Research
Equity Style Small Cap/Blend
Next Earnings Release Nov. 09, 2022 (est.)
Last Earnings Release Aug. 04, 2022
Next Ex-Dividend Date N/A
Last Ex-Dividend Date N/A

Dividends

Dividend Per Share (TTM) --
2017
2018
2019
2020
2021
No data available
 
6.00%
4.00%
2.00%
 
Yield to Market 0.00
Yield to Sector 0.00
Yield to Industry 0.00
Last Dividend Amt. --
Dividend Frequency --
Last Ex-Dividend Date --
Yield (TTM) 0.00%
Forward Yield --
Payout Ratio 0.00%
Cash Payout Ratio 0.00%
Consistent Payer (5Y) No
Consistent Growth (5Y) No

Ownership

Insider Ownership Percentage Upgrade
Jul '20
Nov '20
Mar '21
 
80.00%
40.00%
10.00%
 

Short Interest

Short Interest Upgrade
Percent of Shares Outstanding Short Upgrade
Jul '20
Nov '20
Mar '21
 
80.00%
40.00%
10.00%
 

Total Returns Comparison

Edit comparables

Annual Total Returns Versus Peers

Edit comparables
Loading chart...
Name
2015
2016
2017
2018
2019
2020
2021
YTD
--
--
-62.14%
-27.63%
306.9%
303.9%
93.07%
-47.05%
1.38%
11.96%
21.83%
-4.38%
31.49%
18.40%
28.71%
-8.98%
--
--
--
--
--
54.43%
18.78%
-8.48%
3.99%
-33.29%
70.64%
37.27%
10.61%
11.53%
2.82%
-40.44%
-58.68%
-88.50%
-99.97%
-99.39%
-89.16%
-15.67%
-56.75%
-41.94%
-44.02%
-2.15%
19.27%
24.31%
-52.35%
107.0%
-47.43%
-54.65%
As of August 15, 2022.

Profile

Edit
Fulgent Genetics Inc is a technology company that focuses on genetic testing to provide physicians with clinically actionable diagnostic information. Genetic testing offers the possibility of early identification of a disease or a genetic predisposition to disease and enhanced disease treatment and prognosis. Fulgent's product portfolio includes Genes & Panels, Known Mutation, Genomic Testing, Hereditary Cancer, Carrier Screening, Tumor Profiling, and Sequencing Service. Its customers are categorized as Insurance; Institutional, which includes hospitals, medical institutions, laboratories, governmental bodies, municipalities, and large corporations; and Patients. The geographical segments are the United States, which generates the vast majority of the revenue; and Foreign.
URL https://www.fulgentgenetics.com
Investor Relations URL https://fulgentgenetics.gcs-web.com
HQ State/Province California
Sector Healthcare
Industry Diagnostics & Research
Equity Style Small Cap/Blend
Next Earnings Release Nov. 09, 2022 (est.)
Last Earnings Release Aug. 04, 2022
Next Ex-Dividend Date N/A
Last Ex-Dividend Date N/A

Ownership

Insider Ownership Percentage Upgrade
Jul '20
Nov '20
Mar '21
 
80.00%
40.00%
10.00%
 

Short Interest

Short Interest Upgrade
Percent of Shares Outstanding Short Upgrade
Jul '20
Nov '20
Mar '21
 
80.00%
40.00%
10.00%
 

Top Fund Holders

Symbol Dollars Invested % Weight
CALF 21.26M USD 1.93%
GNOM 5.035M USD 1.93%
GERM 507905.0 USD 1.72%
RYWCX 307222.0 USD 1.57%
RZG 1.929M USD 1.34%
JSML 1.203M USD 1.32%
HIL259 2.261M USD 1.07%
EES 3.014M USD 0.45%

Top Portfolio Holders

0 of 0

Other Resources

Whale Wisdom 13F Filings
Seeking Alpha Call Transcripts
Morningstar Insider Trading
Nasdaq Institutional Ownership
Nasdaq Option Chain
SEC SEC Filings
Twitter FLGT Tweets